Alain Bélanger
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Endocrinologie et génomique
- Adresse
- 2705, boulevard Laurier, T-3-67
Québec (Québec)
CANADA G1V 4G2 - Téléphone
- +1 418-656-4141, poste 46442
- Télécopieur
- +1 418-654-2298
- Courriel
- alain.belanger@ap.ulaval.ca
Publications récentes (voir toutes les publications de ce chercheur)
Audet-Walsh E, Lepine J, Gregoire J, Plante M, Caron P, Tetu B, Ayotte P, Brisson J, Villeneuve L, Belanger A, Guillemette C. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. The Journal of clinical endocrinology and metabolism,
2011. 96: E330-9
Ekstrom L, Schulze JJ, Guillemette C, Belanger A, Rane A. Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene. Pharmacogenetics and genomics,
2011. 21: 325-32
Paquet S, Fazli L, Grosse L, Verreault M, Tetu B, Rennie PS, Belanger A, Barbier O. Differential Expression of the Androgen-Conjugating UGT2B15 and UGT2B17 Enzymes in Prostate Tumor Cells during Cancer Progression. The Journal of clinical endocrinology and metabolism,
2011. Epub
Olsson M, Ekstrom L, Guillemette C, Belanger A, Rane A, Gustafsson O. Correlation between circulatory, local prostatic, and intra-prostatic androgen levels. The Prostate,
2011. 71: 909-14
Giton F, Fiet J, Cornu JN, Cussenot O, Belanger A, Urien S, Oliva A, Blanchet P, Multigner L. Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry. European journal of endocrinology / European Federation of Endocrine Societies,
2011. 165: 917-24
Trottier J, El Husseini D, Perreault M, Paquet S, Caron P, Bourassa S, Verreault M, Inaba TT, Poirier GG, Belanger A, Guillemette C, Trauner M, Barbier O. The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liver. The Journal of biological chemistry,
2010. 285: 1113-21
Lepine J, Audet-Walsh E, Gregoire J, Tetu B, Plante M, Menard V, Ayotte P, Brisson J, Caron P, Villeneuve L, Belanger A, Guillemette C. Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. The Journal of clinical endocrinology and metabolism,
2010. 95: 2689-98
Spitz IM, Chertin B, Fridmans A, Farkas A, Belanger A, Hartman H, Labrie F. Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists. Prostate cancer and prostatic diseases,
2009. 12: 100-3
Labrie F, Cusan L, Gomez JL, Martel C, Berube R, Belanger P, Belanger A, Vandenput L, Mellstrom D, Ohlsson C. Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer. The Journal of steroid biochemistry and molecular biology,
2009. 113: 52-6
Caron P, Audet-Walsh E, Lepine J, Belanger A, Guillemette C. Profiling endogenous serum estrogen and estrogen-glucuronides by liquid chromatography-tandem mass spectrometry. Analytical chemistry,
2009. 81: 10143-8
